申请人:USV Pharmaceutical Corporation
公开号:US04440929A1
公开(公告)日:1984-04-03
Provided are imidazoquinoxalines of the structures: ##STR1## wherein R.sub.1, R.sub.5, R.sub.6 and R.sub.7 are independently H, alkyl, aryl, alkenyl, alkynyl, hydroxy, hydroxyalkyl, alkoxy, mercapto, mercaptoalkyl, alkylthio, amino, alkylamino, aminoalkyl, carboxaldehyde, carboxylic acid and salts thereof, carbalkoxy, alkanoyl, cyano, nitro, halo, trifluoromethyl, alkylsulfonyl, sulfonamido, or R.sub.1, R.sub.5, R.sub.6 and R.sub.7 may be taken together with the adjacent group to form a methylenedioxy group. R.sub.4 is H, alkyl, alkenyl, alkynyl, aryl, aralkyl, hydroxy or alkanoyl. R.sub.3 is H, cyano, tetrazolo, carboxaldehyde, hydroxyalkyl, carboxylic acid and salts thereof or derivatives thereof such as esters or amides in which the substituent on the ester oxygen or amide nitrogen is alkyl, aryl, hydroxyalkyl, alkoxyalkyl or amino alkyl. R.sub.2 and R.sub.8 are independently H, alkyl, aryl, halo, amino, alkylamino, arylamino, hydroxyamino, hydroxy, alkoxy, mercapto or alkylthio, and X is oxygen, sulfur, imino, and hydroxyimino.
提供的是结构为:##STR1##的咪唑喹喔啉化合物,其中R.sub.1、R.sub.5、R.sub.6和R.sub.7独立地是H、烷基、芳基、烯基、炔基、羟基、羟基烷基、烷氧基、巯基、巯基烷基、烷基硫基、氨基、烷基氨基、氨基烷基、羰基、羧醛、羧酸及其盐、羰基酯、烷酰基、氰基、硝基、卤素、三氟甲基、烷基磺酰基、磺胺基或R.sub.1、R.sub.5、R.sub.6和R.sub.7可与相邻基团结合形成亚甲二氧基基团。R.sub.4是H、烷基、烯基、炔基、芳基、芳基烷基、羟基或烷酰基。R.sub.3是H、氰基、四唑基、羧醛、羟基烷基、羧酸及其盐或其衍生物,如酯或酰胺,其中酯氧或酰胺氮上的取代基是烷基、芳基、羟基烷基、烷氧基烷基或氨基烷基。R.sub.2和R.sub.8独立地是H、烷基、芳基、卤素、氨基、烷基氨基、芳基氨基、羟基氨基、羟基、烷氧基、巯基或烷基硫基,X是氧、硫、亚胺或羟亚胺。